MitraClip System is a minimally invasive mitral valve repair device
Abbott has received the 2020 Prix Galien USA Award for Best Medical Technology for its MitraClip System, a leading minimally invasive mitral valve repair device. The award recognises excellence in scientific innovation that improves the state of humankind. MitraClip was selected from a field of 17 other medical technology nominees.
“MitraClip is a first-of-its-kind, life-saving device that has transformed the lives of more than 100,000 people living with leaky mitral valves, many of whom were not treatable with open-heart mitral valve surgery – leaving them with few to no options. We are honoured by this prestigious recognition by the Galien Foundation – a testament to our relentless pursuit to develop innovative treatment options for people living with structural heart conditions that allow them to live better, healthier lives,” said Michael Dale, Senior Vice President, Abbott’s structural heart business.”
